{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O14818",
      "entity_text" : "HSPC",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:64964",
      "entity_text" : "cyclam",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "the cyclam based antagonist AMD3100 (plerixafor) allows mobilization of HSPC for autografting upon myeloablative treatment XREF_BIBR.",
  "reading_complete" : "2020-08-02T07:33:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T07:26:53Z",
  "trigger" : "allows",
  "evidence" : [ "cyclam-based antagonist AMD3100 (plerixafor) allows mobilization of HSPC" ],
  "pmc_id" : "4377730",
  "score" : 0
}